Skip to main content
Michelle Kittleson, MD, Cardiology, Beverly Hills, CA

Michelle Kittleson MD PhD

Heart Failure & Transplantation


Director, Heart Transplant Fellowship

Join to View Full Profile
  • Cedars-Sinai Heart Institute 8670 Wilshire BlvdBeverly Hills, CA 90211

  • Phone+1 310-248-8300

  • Fax+1 310-248-8333

Dr. Kittleson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Michelle Kittleson is a cardiologist in Los Angeles, CA and is affiliated with Cedars-Sinai Medical Center. She received her medical degree from Yale University School of Medicine and has been in practice 18 years. She specializes in heart failure & transplantation and is experienced in general cardiology.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2002 - 2005
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1999 - 2002
  • Yale School of Medicine
    Yale School of MedicineClass of 1999

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2026
  • MD State Medical License
    MD State Medical License 2003 - 2006
  • Advanced Heart Failure and Transplant Cardiology
    American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • Cardiovascular Disease
    American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients with Heart Failure with Reduced Ejection Fraction in US Clinical Practice  
    Muthiah Vaduganathan, Javed Butler, Paul A Heidenreich, Michelle M Kittleson, Anjali Tiku Owens, Pamela N Peterson, Clyde W Yancy, Gregg C Fonarow, JAMA Cardiology
  • The Trials of Women in Cardiology  
    Michelle Kittleson, MD, JACC: Cardiovascular Imaging
  • Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) Pandemic  
    Lauren Sinnenberg, Nosheen Reza, Michelle M Kittleson, Veli K Topkara, Maryjane A Farr, JAMA Cardiology
  • Join now to see all

Lectures

  • The Invisible Hand — Medical Care During the Pandemic 
    Cedars Sinai Medical Center, Riverside, California - 9/15/2012

Authored Content

  • Clinical Outcomes of Older Adults in the US Listed for Heart TransplantationNovember 2021
  • Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
  • Trends in US Heart Transplant Waitlist Activity and Volume During the Coronavirus Disease 2019 (COVID-19) PandemicJuly 2020
  • The Invisible Hand — Medical Care During the PandemicApril 2020
  • ACC CardiaCast: The Five Most Important Things to Know About HCMMarch 2020
  • Join now to see all

Press Mentions

  • ACC.25: Smidt Heart Institute Experts Present Late-Breaking Research
    ACC.25: Smidt Heart Institute Experts Present Late-Breaking ResearchMarch 25th, 2025
  • ‘A Turning Point’ in Heart Failure
    ‘A Turning Point’ in Heart FailureFebruary 26th, 2025
  • Heart Failure Deaths Are Rising. New Treatments Could Help
    Heart Failure Deaths Are Rising. New Treatments Could HelpFebruary 18th, 2025
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: